Alembic Pharma has received USFDA approval for a generic drug, strengthening its presence in the US market and expanding its generics portfolio.

MIRAMAR, Fla., Feb. 12, 2026 /PRNewswire/ -- DifGen Pharmaceuticals, a leading US based generic pharmaceutical company, today announced that it has received approval from the U.S. Food and Drug ...

Jointly developed HIV-1 therapy leverages STEERLife's proprietary solvent-free FragMelt™ continuous processing platform to address complex formulation challenges NEW YORK and BENGALURU, India, Jan. 13 ...

Lupin said it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Brivaracetam Oral Solution 10 mg/mL.

Cipla USA Inc. the wholly owned subsidiary of Cipla Limited(BSE: 500087; NSE: CIPLA; and hereafter referred to as "Cipla") today announced the launch of Liraglutide Injection, 18 mg/3 mL (6 mg/mL) ...

Lupin receives US FDA approval for brivaracetam oral solution: Our Bureau, Mumbai Wednesday, February 25, 2026, 14:20 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced ...

Mumbai: Mumbai-based pharmaceutical major Lupin Limited has received approval from the US Food and Drug Administration (USFDA) for its Brivaracetam Oral Solution 10 mg/mL and has launched ...

NEW YORK and BENGALURU, India, Jan. 13, 2026 /PRNewswire/ -- Marking a significant milestone in the global effort to expand access to advanced HIV therapies, STEERLife (the life sciences division of ...